Abe Hiroshi, Yoshizawa Kai, Kitahara Takuya, Aizawa Ryoichi, Matsuoka Mika, Aizawa Yoshio
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Jikei University School of Medicine, Aoto Hospital, Tokyo, Japan.
J Gastroenterol. 2008;43(12):967-74. doi: 10.1007/s00535-008-2264-8. Epub 2008 Dec 24.
This study was carried out to clarify the carcinogenic factors associated with nonviral hepatocellular carcinoma (HCC).
A total of 320 HCC patients diagnosed and treated from January 2000 to December 2006 were enrolled. The clinical characteristics of non-B non-C HCC patients were examined to determine possible carcinogenic factors.
Of 320 HCC patients, 64 were classified as having non-B non-C HCC. The proportion of non-B non-C HCC increased from 17.8% in 2000 to 28.6% in 2006. Non-B non-C HCC patients had a significantly higher rate of early stage cirrhosis (Child-Pugh classification) than viral HCC patients. Significantly fewer non-B non-C HCC patients had periodic intensive medical assessments than viral HCC patients. Forty-five non-B non-C HCC patients were habitual alcohol drinkers, ten had nonalcoholic fatty liver disease (NAFLD), and seven had no apparent etiology. In habitual drinkers, the stage of underlying liver disease varied widely, while most NAFLD patients had early stage cirrhosis. On the other hand, more than half of the patients with HCC of undetermined etiology had noncirrhotic liver disease. Among habitual drinkers, the underlying liver disease was more progressive, and the T stage was more advanced in those with high daily alcohol intake than in those with low daily alcohol intake. Periodic intensive medical assessments were crucial for detecting early stage HCC.
Alcohol consumption and NAFLD may be important etiological factors in non-B non-C HCC. Periodic medical assessments for all patients with non-B non-C cirrhosis are crucial for early diagnosis and curative therapy.
本研究旨在阐明与非病毒性肝细胞癌(HCC)相关的致癌因素。
纳入2000年1月至2006年12月期间诊断并接受治疗的320例HCC患者。检查非B非C型HCC患者的临床特征以确定可能的致癌因素。
在320例HCC患者中,64例被归类为非B非C型HCC。非B非C型HCC的比例从2000年的17.8%增至2006年的28.6%。非B非C型HCC患者早期肝硬化(Child-Pugh分级)的发生率显著高于病毒性HCC患者。接受定期强化医学评估的非B非C型HCC患者明显少于病毒性HCC患者。45例非B非C型HCC患者为习惯性饮酒者,10例患有非酒精性脂肪性肝病(NAFLD),7例病因不明。在习惯性饮酒者中,潜在肝病的阶段差异很大,而大多数NAFLD患者为早期肝硬化。另一方面,病因不明的HCC患者中超过一半患有非肝硬化性肝病。在习惯性饮酒者中,潜在肝病进展更明显,每日酒精摄入量高者的T分期比摄入量低者更晚。定期强化医学评估对于早期发现HCC至关重要。
饮酒和NAFLD可能是非B非C型HCC的重要病因。对所有非B非C型肝硬化患者进行定期医学评估对于早期诊断和根治性治疗至关重要。